Beta-Fuoxymorphamine Explained

beta-Fuoxymorphamine (β-fuoxymorphamine) is an opioid acting at μ-opioid receptors. It is used experimentally.[1] [2]

See also

Notes and References

  1. Portoghese PS, Takemori AE . Different receptor sites mediate opioid agonism and antagonism . Journal of Medicinal Chemistry . 26 . 10 . 1341–3 . October 1983 . 6312042 . 10.1021/jm00364a001 .
  2. Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, Kato HE, Livingston KE, Thorsen TS, Kling RC, Granier S, Gmeiner P, Husbands SM, Traynor JR, Weis WI, Steyaert J, Dror RO, Kobilka BK . 6 . Structural insights into µ-opioid receptor activation . Nature . 524 . 7565 . 315–21 . August 2015 . 26245379 . 4639397 . 10.1038/nature14886 . 2015Natur.524..315H .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Beta-Fuoxymorphamine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.